A Nigerian scholar, Elizabeth Kehinde Oladipo, has received international commendation after presenting her pioneering research on the impact of HIV on the brain at the University of Nebraska Medical Center (UNMC), Omaha, USA.

 

Her study focuses on the HIV Tat protein, a molecule that remains active in the brain even when patients are on combined antiretroviral therapy (cART). According to her findings, Tat plays a key role in long-term neurological damage, including memory loss, cognitive decline, and neurodegeneration.

 

Speaking during a poster presentation, Oladipo explained that while antiretroviral treatment has transformed HIV into a manageable disease, Tat remains a hidden but persistent threat.

 

“Tat persists in the brain long after the virus has been suppressed in the blood, which makes it particularly dangerous. My research is focused on understanding how Tat interacts with brain cells, so we can develop ways to protect patients from long-term neurological complications,” she said.

 

Her work drew widespread praise from senior scientists and researchers, who described it as a potential breakthrough in addressing HIV-associated neurocognitive disorders, a challenge that continues to affect patients despite major advances in treatment.

 

With over 39 million people living with HIV worldwide, and Nigeria among the countries most affected, experts say Oladipo’s findings could influence new strategies to reduce the virus’s hidden impact on the brain, ultimately improving the quality of life for millions.

 

Oladipo, who has dedicated her career to advancing human health through science, emphasized the human dimension of her work.

 

“This research is not just about laboratory work; it is about people’s lives. If we can understand Tat at the molecular level, we can find ways to protect the brain and help patients live healthier, fuller lives,” she noted.

 

Her achievement not only marks an important step in HIV research but also highlights the growing impact of Nigerian scientists on the global stage, reinforcing Africa’s vital role in tackling some of today’s most pressing health challenges.